Thymic Carcinoma

This page contains recent news articles, when available, and an overview of Thymic Carcinoma but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Thymic Carcinoma

Dose-dense Chemotherapy for Disseminated Thymoma Reported  -  ‎Nov 5, 2009‎
Cancer ConsultantsPatients with thymic carcinoma, carcinoid, and lymphoma were excluded from this study. Patients received nine weeks of therapy with vincristine, doxorubicin ...

John Lovretta/The Hawk Eye  -  07 Aug 2009
Burlington Hawk EyeCancer survivor Carol Fritz holds a photograph Tuesday of her son Dennis “ Tunk? Fritz, who she lost to thymic carcinoma last summer, in her Wever home.

Comparison of patterns of relapse in thymic carcinoma and thymoma  -  ‎Jul 20, 2009‎
The Journal of Thoracic and Cardiovascular SurgeryResults: During the period 1995–2006, 120 patients with thymic tumors underwent surgical intervention, including 23 patients with thymic carcinoma and 97

Robotic surgery at AIIMS for rare neuro disorder  -  Jun 23, 2008
Times of India,Incidentally, thymectomy is also done on patients with thymic carcinoma (a rare type of thymus gland cancer) and non-metastic thymoma.

Kent firefighter mourned by hundreds of colleagues across state  -  Jun 14, 2008
PNW Local News,Hauer died June 3 after a year-long battle with thymic carcinoma, a rare type of thymus-gland cancer. Fifty fire vehicles from departments across the state

CuraGen and TopoTarget Announce Initiation of an NCI-sponsored ...  -  Dec 19, 2007
CNNMoney.comPatients with either thymoma or thymic carcinoma who have received at least one prior platinum-containing chemotherapy regimen are eligible for enrollment.

CRGN: Begins Ph II Trial of IV Belinostat for Thymoma and Thymic ...  -  Dec 19, 2007
Trading Markets (press release),Thymoma and thymic carcinoma are rare tumors of the thymus with fewer than 1000 patients diagnosed in the United States per year.

CuraGen And TopoTarget Commences Phase II Study Of Belinostat To ...  -  Dec 19, 2007
Trading Markets (press release),...trail of intravenous Belinostat, a small molecule histone deacytylase inhibitor, to treat patients with previously treated thymoma and thymic carcinoma.

CuraGen, TopoTarget Begin Patient Dosing In Phase II Clinical ...  -  Dec 19, 2007
Trading Markets (press release),...trial examining the efficacy and safety of intravenous belinostat for the treatment of patients with previously-treated thymoma and thymic carcinoma.

CuraGen, TopoTarget Dose First Patients in Belinostat Trial  -  Dec 19, 2007
FDA news (subscription),...begun a Phase II trial evaluating the efficacy and safety of intravenous belinostat in patients with previously treated thymoma and thymic carcinoma.

Market Report -- In Play (WIRES)  -  Dec 19, 2007
MSN Money...a small molecule histone deacetylase inhibitor, for the treatment of patients with previously-treated thymoma and thymic carcinoma.

Feasibility of multimodality therapy including extended resections ...  -  Dec 11, 2007
The Journal of Thoracic and Cardiovascular SurgeryPatients who had undergone prior resection and patients with a diagnosis of thymic carcinoma only or thymic carcinoid were excluded from the analysis.



Background information on Thymic Carcinoma [When available]

In medicine, carcinoma is any cancer that arises from epithelial cells. It is malignant by definition: carcinomas invade surrounding tissues and organs, and may spread to lymph nodes and distal sites (metastasis). Carcinoma in situ (CIS) is a pre-malignant condition, in which cytological signs of malignancy are present, but there is no histological evidence of invasion through the epithelial basement membrane.

Types of carcinoma

Carcinoma, like all neoplasia, is classified by its histopathological appearance. Adenocarcinoma and squamous cell carcinoma, two common descriptive terms for tumours, reflect the fact that these cells may have glandular or squamous cell appearances respectively. Severely anaplastic tumours might be so undifferentiated that they do not have a distinct histological appearance.

Sometimes a tumour is referred to by the presumptive organ of the primary (eg carcinoma of the prostate) or the putative cell of origin (hepatocellular carcinoma, renal cell carcinoma).

Search the web for more resources on Thymic Carcinoma



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy